PANNACCI, MARILOU

PANNACCI, MARILOU  

Dipartimento di Biotecnologie Mediche e Medicina Traslazionale  

Mostra records
Risultati 1 - 20 di 22 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
2-N-acylaminoalkylindoles : design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists 30-ago-2001 V. LuciniM. PannacciF. Fraschini + Article (author) -
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide : synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors 1-gen-2011 V. LuciniM. PannacciF. Scaglione + Article (author) -
Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma 1-lug-2004 L. BelloV. LuciniCOSTA, FRANCESCOM. PluderiC.G. GiussaniF. AcerbiG.G. CarrabbaM. Pannacci + Article (author) -
Comparison of the potency of 10 different brands of Serenoa repens extracts 1-mag-2012 F. ScaglioneV. LuciniM. PannacciS. Dugnani + Article (author) -
Comparison of the potency of different brands of serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells 10-ott-2008 F. ScaglioneV. LuciniM. Pannacci + Article (author) -
Customizing antiangiogenesis therapy toward vessel normalization results in a long-term glioma growth control 1-ott-2006 L. BelloV. LuciniM. PannacciF. AcerbiC. GiussaniG. CarrabbaS. Gaini + Article (author) -
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors 1-gen-2010 V. LuciniPANNACCI, MARILOUF. Scaglione + Article (author) -
In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol 1-gen-2012 F. ScaglioneS. DugnaniV. LuciniM. Pannacci + Article (author) -
Incidence and risk factors of neurosurgical site infections : results of a prospective multicenter cohort study on 6359 surgeries 1-feb-2021 Pannacci, MarilouDi Meco, Francesco + Article (author) -
Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo 15-mag-2003 C. GiussaniG. CarrabbaM. PluderiV. LuciniM. PannacciD. CaronzoloF. CostaR. VillaniL. Bello + Article (author) -
The melatonin receptor in the human brain: cloning experiments and distribution studies 1-lug-1996 M. PannacciV. LuciniF. Fraschini + Article (author) -
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands 1-gen-2009 V. LuciniM. PannacciA. CaronnoF. Scaglione + Article (author) -
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands 27-dic-2007 V. LuciniM. PannacciF.L. FraschiniF. Scaglione + Article (author) -
Reassessing the melatonin pharmacophore-enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue 15-mag-2006 V. LuciniM. Pannacci + Article (author) -
The standardised G115 Panax ginseng C.A. Meyer extract: a review of its properties and usage 1-gen-2005 F. ScaglioneM. Pannacci + Article (author) -
Synthesis and the biological activity of new melatonin dimeric derivatives 1-gen-2007 F. FraschiniM. PannacciV. Lucini + Article (author) -
Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists 1-dic-2007 V. LuciniM. PannacciCARONNO, ALESSIAF. Fraschini + Article (author) -
Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands 1-apr-2001 V. LuciniM. PannacciF. Fraschini + Article (author) -
Tailoring of anti angiogenic therapies to tumor stage improves therapeutic efficacy in mouse models of human gliomas 1-gen-2005 C. GiussaniG. CarrabbaV. LuciniM. PannacciS.M. GainiL. Bello + Article (author) -
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands : requirements for subtype selectivity and intrinsic activity modulation 10-apr-2003 V. LuciniM. PannacciF. Fraschini + Article (author) -